Stem Sel Srl

Stem Sel Srl is an Italian academic spin-off from the University of Bologna, established in 2013.

The company focuses on the development, production, and commercialization of Celector®, a patented cell chromatograph designed for the label-free separation and quality control of living human stem cells. This innovative technology allows for the collection of stem cells from various discarded adult tissues, including placenta and bone marrow, enhancing the effectiveness and safety of cell-based therapies. Operating in the regenerative medicine, pharmaceutical, and biotechnology sectors, Stem Sel Srl aims to provide healthcare professionals with advanced tools for selecting high-quality stem cells for drug development and clinical applications. The Celector® utilizes dynamic fractionation technology to separate cells based on their natural physical properties, ensuring high purity and viability. The company also collaborates with Burkert for fluidic systems, contributing to its innovative approach in the field.